IFRX logo

InflaRx NV (IFRX) Cash From Investing

Annual CFI

-$19.16 M
-$39.57 M-193.85%

December 31, 2023

Summary

Performance

1-Year Change

-193.85%

3-Year Change

-178.53%

5-Year Change

+83.69%

15-Year Change

-10026.06%

IFRX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.77%
IFRX annual cash flow from investing activities is higher than 28.77% of companies in Healthcare sector

High & Low

All-time High

$24.40 M
IFRX annual cash flow from investing activities is currently -178.53% below its historical high of $24.40 million

3-Year Low

-$30.70 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
IFRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 20, 2025
IFRX next annual earnings announcement is scheduled for Mar 20, 2025

OtherIFRXcash flowmetrics:

Annual CFF

$57.36 M
IFRX annual cash flow from financing activities is $57.36 million

Annual CFO

-$40.94 M
IFRX annual cash flow from operations is -$40.94 million

Annual FCF

-$41.02 M
IFRX annual free cash flow is -$41.02 million

Annual CAPEX

$87.80 K
IFRX annual capital expenditures is $87.80 thousand

Quarterly CFI

$19.97 M
+$13.77 M+222.16%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

IFRX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.69%
IFRX quarterly cash flow from investing activities is higher than 87.69% of companies in Healthcare sector

High & Low

All-time High

$29.71 M
IFRX quarterly cash flow from investing activities is currently -32.79% below its historical high of $29.71 million

3-Year Low

-$39.80 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
IFRX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
IFRX next earnings announcement is scheduled for Mar 20, 2025

OtherIFRXcash flowmetrics:

Quarterly CFF

-$111.20 K
IFRX quarterly cash flow from financing activities is -$111.20 thousand

Quarterly CFO

-$11.25 M
IFRX quarterly cash flow from operations is -$11.25 million

Quarterly FCF

-$11.25 M
IFRX quarterly free cash flow is -$11.25 million

Quarterly CAPEX

$2500.00
IFRX quarterly capital expenditures is $2500.00

TTM CFI

$58.63 M
+$11.90 M+25.47%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

IFRX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.65%
IFRX TTM cash flow from investing activities is higher than 90.65% of companies in Healthcare sector

High & Low

All-time High

$60.10 M
IFRX TTM cash flow from investing activities is currently -2.45% below its historical high of $60.10 million

3-Year Low

-$30.70 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
IFRX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
IFRX next earnings announcement is scheduled for Mar 20, 2025

OtherIFRXcash flowmetrics:

TTM CFF

-$749.70 K
IFRX TTM cash flow from financing activities is -$749.70 thousand

TTM CFO

-$51.93 M
IFRX TTM cash flow from operations is -$51.93 million

TTM FCF

-$52.00 M
IFRX TTM free cash flow is -$52.00 million

TTM CAPEX

$70.80 K
IFRX TTM capital expenditures is $70.80 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IFRX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-193.8%0.0%0.0%
3 y3 years-178.5%0.0%0.0%
5 y5 years+83.7%0.0%0.0%

IFRX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-193.8%+37.6%-32.8%+150.2%at high+290.9%
5 y5-year-178.5%+37.6%-32.8%+150.2%-2.5%+290.9%
alltimeall time-178.5%+83.7%-32.8%+117.8%-2.5%+147.8%

InflaRx NV Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.97 M(+222.2%)
$58.63 M(+25.5%)
Jun 2024
-
$6.20 M(-78.8%)
$46.72 M(+234.7%)
Mar 2024
-
$29.27 M(+818.6%)
$13.96 M(-172.9%)
Dec 2023
-$19.16 M(-193.8%)
$3.19 M(-60.5%)
-$19.16 M(-2.3%)
Sep 2023
-
$8.07 M(-130.4%)
-$19.61 M(-16.1%)
Jun 2023
-
-$26.56 M(+589.7%)
-$23.37 M(+77.7%)
Mar 2023
-
-$3.85 M(-240.9%)
-$13.15 M(-164.4%)
Dec 2022
$20.41 M(-166.5%)
$2.73 M(-36.5%)
$20.41 M(-192.3%)
Sep 2022
-
$4.31 M(-126.4%)
-$22.12 M(+12.4%)
Jun 2022
-
-$16.34 M(-155.0%)
-$19.67 M(-7248.8%)
Mar 2022
-
$29.71 M(-174.7%)
$275.20 K(-100.9%)
Dec 2021
-$30.70 M(-225.9%)
-$39.80 M(-689.1%)
-$30.70 M(+4507.5%)
Sep 2021
-
$6.76 M(+87.4%)
-$666.40 K(-115.1%)
Jun 2021
-
$3.61 M(-385.1%)
$4.41 M(-83.1%)
Mar 2021
-
-$1.26 M(-87.0%)
$26.13 M(+7.1%)
Dec 2020
$24.40 M
-$9.76 M(-182.5%)
$24.40 M(-59.4%)
DateAnnualQuarterlyTTM
Sep 2020
-
$11.83 M(-53.3%)
$60.10 M(+132.5%)
Jun 2020
-
$25.32 M(-945.0%)
$25.85 M(+28.8%)
Mar 2020
-
-$3.00 M(-111.6%)
$20.07 M(-11.9%)
Dec 2019
$22.77 M(-119.4%)
$25.94 M(-215.7%)
$22.77 M(+1054.7%)
Sep 2019
-
-$22.41 M(-214.7%)
$1.97 M(-102.2%)
Jun 2019
-
$19.54 M(-6671.9%)
-$88.16 M(-25.0%)
Mar 2019
-
-$297.40 K(-105.8%)
-$117.57 M(+0.1%)
Dec 2018
-$117.43 M(>+9900.0%)
$5.14 M(-104.6%)
-$117.43 M(-4.2%)
Sep 2018
-
-$112.54 M(+1040.7%)
-$122.63 M(+1108.0%)
Jun 2018
-
-$9.87 M(+6124.9%)
-$10.15 M(+3073.3%)
Mar 2018
-
-$158.50 K(+145.7%)
-$319.90 K(+69.2%)
Dec 2017
-$189.20 K(+222.3%)
-$64.50 K(+4.2%)
-$189.10 K(+51.8%)
Sep 2017
-
-$61.90 K(+76.9%)
-$124.60 K(+98.7%)
Jun 2017
-
-$35.00 K(+26.4%)
-$62.70 K(+126.4%)
Mar 2017
-
-$27.70 K
-$27.70 K
Dec 2016
-$58.70 K(+307.6%)
-
-
Dec 2015
-$14.40 K
-
-

FAQ

  • What is InflaRx NV annual cash flow from investing activities?
  • What is the all time high annual CFI for InflaRx NV?
  • What is InflaRx NV annual CFI year-on-year change?
  • What is InflaRx NV quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for InflaRx NV?
  • What is InflaRx NV quarterly CFI year-on-year change?
  • What is InflaRx NV TTM cash flow from investing activities?
  • What is the all time high TTM CFI for InflaRx NV?
  • What is InflaRx NV TTM CFI year-on-year change?

What is InflaRx NV annual cash flow from investing activities?

The current annual CFI of IFRX is -$19.16 M

What is the all time high annual CFI for InflaRx NV?

InflaRx NV all-time high annual cash flow from investing activities is $24.40 M

What is InflaRx NV annual CFI year-on-year change?

Over the past year, IFRX annual cash flow from investing activities has changed by -$39.57 M (-193.85%)

What is InflaRx NV quarterly cash flow from investing activities?

The current quarterly CFI of IFRX is $19.97 M

What is the all time high quarterly CFI for InflaRx NV?

InflaRx NV all-time high quarterly cash flow from investing activities is $29.71 M

What is InflaRx NV quarterly CFI year-on-year change?

Over the past year, IFRX quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is InflaRx NV TTM cash flow from investing activities?

The current TTM CFI of IFRX is $58.63 M

What is the all time high TTM CFI for InflaRx NV?

InflaRx NV all-time high TTM cash flow from investing activities is $60.10 M

What is InflaRx NV TTM CFI year-on-year change?

Over the past year, IFRX TTM cash flow from investing activities has changed by $0.00 (0.00%)